Equity - Schedule of Common Stock Reserved for Issuance (Details) - shares |
Jun. 30, 2026 |
Mar. 31, 2026 |
|---|---|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Common stock warrants (in shares) | 172,000 | |
| Options outstanding (in shares) | 10,010,000 | 10,464,000 |
| Total (in shares) | 70,469,000 | |
| 2010 Plan | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Options outstanding (in shares) | 7,442,000 | |
| 2021 Plan | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Awards outstanding (in shares) | 7,742,000 | |
| Shares available for future grant (in shares) | 40,045,000 | |
| 2021 ESPP | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Shares available for future grant (in shares) | 12,500,000 | |
| Options outstanding outside the Plans | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Options outstanding (in shares) | 2,568,000 |
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|